Felemban Razaz Abdulaziz, Abduljabbar Maram H, Alnemari Reem M, Alzhrani Rami M, Althobaiti Yusuf S, Aldawsari Mohammed F, Serag Ahmed, Almalki Atiah H
Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences Jeddah Saudi Arabia.
King Abdullah International Medical Research Centre Jeddah Saudi Arabia.
RSC Adv. 2025 Mar 24;15(12):8855-8866. doi: 10.1039/d5ra00519a. eCollection 2025 Mar 21.
A sensitive and selective fluorescence quenching method was developed for the determination of lurasidone using MPA-CdTe quantum dots as a "turn-off" fluorescent probe. The fluorescence intensity of the MPA-CdTe QDs was quenched upon the addition of lurasidone, with the quenching efficiency exhibiting a linear relationship with the lurasidone concentration in the range of 0.02-1.0 μg mL. Stern-Volmer analysis revealed that the quenching mechanism was predominantly static in nature, and thermodynamic studies indicated that the interaction between lurasidone and MPA-CdTe QDs was exothermic and spontaneous in nature. Factors affecting the quenching process, including pH, MPA-CdTe QDs volume, and incubation time, were optimized using a Box-Behnken experimental design. A significant model was obtained with a coefficient of determination ( ) of 0.9547, demonstrating the reliability of the optimization process. The analytical performance of the method was validated according to ICH guidelines, exhibiting good linearity and sensitivity with LOD of 5.90 ng mL and LOQ of 17.70 ng mL. The accuracy and precision of the method were assessed through recovery studies, showing satisfactory results with a mean recovery of 98.65 ± 0.733% and RSD% > 2%. The proposed method was successfully applied to the analysis of lurasidone in pharmaceutical dosage forms, spiked plasma, and environmental water samples, with good recoveries and precision. The greenness and analytical practicality of the method were evaluated using AGREE and BAGI tools, respectively, and the results showed that the proposed method is a greener and more practical alternative to previously reported analytical techniques for the determination of lurasidone. The present study demonstrates the potential of MPA-CdTe QDs as a sensitive and selective fluorescent probe for the determination of lurasidone in various matrices, with good analytical performance and environmental compatibility.
开发了一种灵敏且选择性的荧光猝灭方法,以巯基丙酸修饰的碲化镉量子点(MPA-CdTe量子点)作为“关断型”荧光探针来测定鲁拉西酮。加入鲁拉西酮后,MPA-CdTe量子点的荧光强度猝灭,猝灭效率与鲁拉西酮浓度在0.02 - 1.0 μg/mL范围内呈线性关系。斯特恩-沃尔默分析表明,猝灭机制主要为静态猝灭,热力学研究表明鲁拉西酮与MPA-CdTe量子点之间的相互作用是放热且自发的。采用Box-Behnken实验设计对影响猝灭过程的因素,包括pH值、MPA-CdTe量子点体积和孵育时间进行了优化。得到了一个显著模型,决定系数( )为0.9547,表示优化过程的可靠性。该方法的分析性能按照国际人用药品注册技术协调会(ICH)指南进行了验证,具有良好的线性和灵敏度,检测限为5.90 ng/mL,定量限为17.70 ng/mL。通过回收率研究评估了该方法的准确性和精密度,结果令人满意,平均回收率为98.65 ± 0.733%,相对标准偏差(RSD%)> 2%。所提出的方法成功应用于药物剂型、加标血浆和环境水样中鲁拉西酮的分析,回收率和精密度良好。分别使用AGREE和BAGI工具评估了该方法的绿色度和分析实用性,结果表明所提出的方法是一种比先前报道的用于测定鲁拉西酮的分析技术更绿色、更实用的替代方法。本研究证明了MPA-CdTe量子点作为一种灵敏且选择性的荧光探针用于测定各种基质中鲁拉西酮的潜力,具有良好的分析性能和环境兼容性。
Spectrochim Acta A Mol Biomol Spectrosc. 2025-2-15
Spectrochim Acta A Mol Biomol Spectrosc. 2025-5-5
Spectrochim Acta A Mol Biomol Spectrosc. 2012-9-9
Spectrochim Acta A Mol Biomol Spectrosc. 2020-6-15
Guang Pu Xue Yu Guang Pu Fen Xi. 2008-6
Spectrochim Acta A Mol Biomol Spectrosc. 2024-9-5
Colloids Surf B Biointerfaces. 2014-5-1
Colloids Surf B Biointerfaces. 2024-9